Moving toward a precision medicine approach in metastatic castration-resistant prostate cancer

Lancet Oncol. 2017 Nov;18(11):1436-1437. doi: 10.1016/S1470-2045(17)30718-0. Epub 2017 Oct 9.

Author

Rahul Aggarwal¹

Affiliation

¹ Department of Medicine, University of California, San Francisco, CA 94122, USA.

PMID: 29033098
DOI: 10.1016/S1470-2045(17)30718-0

No abstract available

Publication types

Comment

MeSH terms

Humans
Male
Precision Medicine*
Prostatic Neoplasms, Castration-Resistant*
Taxoids

Substances

Taxoids